P
Prabal Niyogi
Publications - 14
Citations - 97
Prabal Niyogi is an academic researcher. The author has contributed to research in topics: Rotavirus vaccine & Reassortment. The author has an hindex of 6, co-authored 14 publications receiving 82 citations.
Papers
More filters
Journal Article
Macrophage activation syndrome in Kawasaki disease.
TL;DR: 4-year-old boy with Kawasaki Disease treated with intravenous immunoglobulins develops encephalopathy, hepatosplenomegaly and pancytopenia and macrophage activation syndrome is suggested.
Journal ArticleDOI
Complete genotyping of unusual species A rotavirus G12P[11] and G10P[14] isolates and evidence of frequent in vivo reassortment among the rotaviruses detected in children with diarrhea in Kolkata, India, during 2014.
Paulami Mandal,Satarupa Mullick,Mukti Kant Nayak,Anupam Mukherjee,N. K. Ganguly,Prabal Niyogi,Samiran Panda,Mamta Chawla-Sarkar +7 more
TL;DR: From the G/P constellation of all RVA isolates, it could be concluded that approximately one quarter had likely arisen from reassortment events in vivo among RVAs of ‘usual’ genotypes.
Journal ArticleDOI
Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL® with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine.
Sajjad Desai,Niraj Rathi,Anand Kawade,Padmasani Venkatramanan,Ritabrata Kundu,Sanjay Lalwani,Anand Prakash Dubey,J. Venkateswara Rao,D. Narayanappa,Radha Ghildiyal,Nithya J Gogtay,P. Venugopal,Sonali Palkar,Renuka Munshi,Ashish Bavdekar,Sanjay Juvekar,N. K. Ganguly,Prabal Niyogi,Kheya Ghosh Uttam,Alpana Kondekar,Dipti Kumbhar,Smilu Mohanlal,Mukesh C Agarwal,Parvan Shetty,Kalpana Antony,Bhagwat Gunale,Abhijeet Dharmadhikari,Jagdish Deshpande,Uma P. Nalavade,Deepa Sharma,Anurag Bansal,Yuxiao Tang,Jorge Flores,Prasad S. Kulkarni +33 more
TL;DR: BRV-PV does not interfere with the immunogenicity of concomitantly administered routine infants vaccines.
Journal ArticleDOI
Immunogenicity and lot-to-lot consistency of a ready to use Liquid Bovine-Human Reassortant Pentavalent Rotavirus Vaccine (ROTASIIL - Liquid) in Indian infants.
Anand Kawade,Sudhir Babji,Veena G Kamath,Abhishek V Raut,Chandra Mohan Kumar,Ritabrata Kundu,Padmasani Venkatramanan,Sanjay Lalwani,Ashish Bavdekar,Sanjay Juvekar,Girish Dayma,Rakesh Patil,Muralidhar M Kulkarni,Asha Hegde,Dinesh M Nayak,Bishan S Garg,Subodh S Gupta,Smita Priyadarshan Jategaonkar,Nidhi Bedi,Chetna Maliye,N. K. Ganguly,Kheya Ghosh Uttam,Prabal Niyogi,Sonali Palkar,Neeta Hanumante,Nidhi Goyal,Alok Arya,Mohd. Aslam,Varsha Parulekar,Abhijeet Dharmadhikari,Dutta Gaikwad,Jagdish Kamalaji Zade,Sajjad Desai,Gagandeep Kang,Prasad S. Kulkarni +34 more
TL;DR: The immunological non-inferiority of LBRV-PV against Rotasiil® as well as lot-to-lot consistency of L BRV-pV was demonstrated and LBRVs safety profile had safety profile similar toRotasiil®,.
Journal ArticleDOI
A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.
Niraj Rathi,Sajjad Desai,Anand Kawade,Padmasani Venkatramanan,Ritabrata Kundu,Sanjay Lalwani,Anand Prakash Dubey,J. Venkateswara Rao,D. Narayanappa,Radha Ghildiyal,Nithya J Gogtay,P. Venugopal,Sonali Palkar,Renuka Munshi,Gagandeep Kang,Sudhir Babji,Ashish Bavdekar,Sanjay Juvekar,N. K. Ganguly,Prabal Niyogi,Kheya Ghosh Uttam,H S Rajani,Alpana Kondekar,Dipti Kumbhar,Smilu Mohanlal,Mukesh C Agarwal,Parvan Shetty,Kalpana Antony,Bhagwat Gunale,Abhijeet Dharmadhikari,Yuxiao Tang,Prasad S. Kulkarni,Jorge Flores +32 more
TL;DR: Pentavalent reassortant rotavirus vaccine (BRV-PV) was tested for lot-to-lot consistency in Indian infants and demonstrated safety profile similar to licensed Rotarix®.